FXYD3-pep SKSK did not augment the effect of Dox on pancreatic Panc-1 cells that do not express FXYD3 (Figure 4C) or on the breast cancer cell line MDA-MB-468 that expresses FXYD3 at a low level (Figure 4D). This evidence concerns the gene FXYD3 and breast carcinoma.